ClinicalTrialsFinder
RecruitingNot ApplicableNCT05707078

PET/CT Follow up for Head and Neck Squamous Cell Carcinoma

Sponsor

Rigshospitalet, Denmark

Enrollment

600 participants

Start Date

Mar 7, 2023

Study Type

INTERVENTIONAL

Conditions

Head and Neck Squamous Cell CarcinomaPET/CT

Summary

PET/CT follow up for Head and Neck Squamous Cell Carcinoma The following is a presentation of a prospective protocol, named PET/CT follow up for Head and Neck Squamous Cell Carcinoma (PET Follow), including patients who have completed radiotherapy treatment for squamous cell carcinoma of the head and neck (HNSCC). The purpose of this study is to investigate the diagnostic performance of 18F-fluorodeoxy-D-glucose (FDG) Positron Emission Tomography/ Computed Tomography (PET/CT) in patients with HNSCC after curative intended treatment.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Informed consent
  • Age above 18
  • Completed curative treatment for HNSCC of the oral cavity, nasopharynx, oropharynx, hypopharynx or larynx

Exclusion Criteria4

  • Patient refusal
  • Patients with clinical N0 neck
  • Patients who had neck dissections prior to radiotherapy
  • Patients who are clinical inoperable for any reason

Interventions

PROCEDURENeck dissection

Based on PET/CT scan patients will undergo neck dissection.

Locations(1)

Department of Otorhinolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05707078

Related Trials

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

NCT069800383 locations

Study of CHS-114 in Participants With Advanced Solid Tumors

NCT0563564316 locations

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

NCT043753841 location

A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

NCT0680685257 locations

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT0711504311 locations